B

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Manager for the Drug Product Development and Analysis Team

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeHørsholm, DenmarkNo salary listedIn-person

About the Job

Requirements

  • A Master of Science degree in Biotechnology, Human Biology, Biochemistry, Chemical Engineering, Pharmacy, or a related field.
  • Three to five years of relevant experience in the biotechnology industry or academia.
  • Previous experience with pharmaceutical analyses, such as chromatographic methods, particle methods, and protein methods.
  • Previous experience with formulation development and statistical data analysis, and an understanding of protein chemistry.
  • Fluency in spoken and written English.
  • A strong interest in consistently delivering high-quality analytical data and supporting the department’s development studies.
  • Strong teamwork and people skills, and the ability to engage in cross-functional dialogue.
  • A proactive, calm, and positive attitude, with adaptability to new priorities.

Responsibilities

  • Head the Drug Product Development and Analysis Team, consisting of three Scientists and three Technicians, reporting to the Head of Process Development.
  • Drive the daily operation of the team, set scientific direction, and ensure the development of team members.
  • Review analytical results and maintain analytical methods.
  • Drive execution of analytical tasks in the team.
  • Ensure established analysis assays run smoothly and deliver high-quality data on time.
  • Support the team in developing new assays to advance the department.
  • Communicate daily with the team and collaborate closely with Production, Quality Control, and R&D.

Desired Qualifications

  • A PhD in protein chemistry or a related topic.

About the Company

Bavarian Nordic

Develops cancer immunotherapies and vaccines

Bavarian Nordic develops, manufactures, and sells vaccines and cancer immunotherapies. Its vaccines and immunotherapies aim to train the body's immune system to recognize and attack cancer cells or infectious agents. The company operates as a fully integrated biotechnology business, handling development, production, and commercialization, and it collaborates with partners and licensing agreements to bring its products to market. A key differentiator is its track record, including European marketing authorization for an Ebola vaccine and a licensing deal for a COVID-19 vaccine, plus ongoing partnerships. The company's goal is to improve global health by reducing the risk of infectious diseases and by improving cancer treatment outcomes.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Gentofte Municipality, Denmark
Founded
1994

Recently Posted Jobs

Explore more opportunities at Bavarian Nordic

See more jobs